trending Market Intelligence /marketintelligence/en/news-insights/trending/kXM_GT9eyxJKpvh7tjubbg2 content esgSubNav
In This List

Perrigo gets FDA approval for over-the-counter equivalents to GSK's nicotine gum

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Perrigo gets FDA approval for over-the-counter equivalents to GSK's nicotine gum

Perrigo Co. PLC received approvals from the U.S. FDA for abbreviated new drug applications referencing GlaxoSmithKline PLC's Nicorette White Ice Mint Gum, a nicotine chewing gum.

These products will be packaged and marketed as store brands or retailers' own label brands to bring alternatives to the GSK product.

Annual sales of Nicorette White Ice Mint Gum for the 12 months ending November were $79 million.